Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 159

1.

Serum amyloid A: A potential biomarker of lung disorders.

Vietri L, Fui A, Bergantini L, d'Alessandro M, Cameli P, Sestini P, Rottoli P, Bargagli E.

Respir Investig. 2019 Nov 7. pii: S2212-5345(19)30165-0. doi: 10.1016/j.resinv.2019.09.005. [Epub ahead of print] Review.

PMID:
31708467
2.

Elevated level of Galectin-1 in bronchoalveolar lavage of patients with idiopathic pulmonary fibrosis.

Bennett D, Bargagli E, Bianchi N, Landi C, Fossi A, Fui A, Sestini P, Refini RM, Rottoli P.

Respir Physiol Neurobiol. 2019 Oct 30:103323. doi: 10.1016/j.resp.2019.103323. [Epub ahead of print]

PMID:
31678459
3.

The effect of cigarette smoking on bronchoalveolar lavage protein profiles from patients with different interstitial lung diseases.

Bargagli E, Cameli P, Carleo A, Refini RM, Bergantini L, D'alessandro M, Vietri L, Perillo F, Volterrani L, Rottoli P, Bini L, Landi C.

Panminerva Med. 2019 Sep 24. doi: 10.23736/S0031-0808.19.03754-6. [Epub ahead of print]

PMID:
31577091
4.

Pirfenidone in real life: A retrospective observational multicentre study in Italian patients with idiopathic pulmonary fibrosis.

Vancheri C, Sebastiani A, Tomassetti S, Pesci A, Rogliani P, Tavanti L, Luppi F, Harari S, Rottoli P, Ghirardini A, Kirchgaessler KU, Albera C.

Respir Med. 2019 Sep;156:78-84. doi: 10.1016/j.rmed.2019.08.006. Epub 2019 Aug 13.

PMID:
31445389
5.

New concepts in the pathogenesis of sarcoidosis.

Bennett D, Bargagli E, Refini RM, Rottoli P.

Expert Rev Respir Med. 2019 Oct;13(10):981-991. doi: 10.1080/17476348.2019.1655401. Epub 2019 Aug 23.

PMID:
31414923
6.

Serum amyloid A in patients with idiopathic pulmonary fibrosis.

Vietri L, Bennett D, Cameli P, Bergantini L, Cillis G, Sestini P, Bargagli E, Rottoli P.

Respir Investig. 2019 Sep;57(5):430-434. doi: 10.1016/j.resinv.2019.03.010. Epub 2019 Apr 26.

PMID:
31031123
7.

Rituximab Therapy in Interstitial Lung Disease associated with Rheumatoid Arthritis.

Fui A, Bergantini L, Selvi E, Mazzei MA, Bennett D, Pieroni MG, Rottoli P, Bargagli E.

Intern Med J. 2019 Apr 9. doi: 10.1111/imj.14306. [Epub ahead of print]

PMID:
30963656
8.

Prognostic Biomarkers of Sarcoidosis: A Comparative Study of Serum Chitotriosidase, ACE, Lysozyme, and KL-6.

Bergantini L, Bianchi F, Cameli P, Mazzei MA, Fui A, Sestini P, Rottoli P, Bargagli E.

Dis Markers. 2019 Mar 3;2019:8565423. doi: 10.1155/2019/8565423. eCollection 2019.

9.

Combined sarcoidosis and idiopathic pulmonary fibrosis (CSIPF): A novel disease phenotype?

Bianchi F, Piccioli C, Rosi E, Carobene L, Spina D, Mazzei MA, Bartolucci M, Moroni C, Novelli L, Rottoli P, Bargagli E.

Respir Med. 2019 Mar 16. pii: S0954-6111(19)30078-2. doi: 10.1016/j.rmed.2019.02.022. [Epub ahead of print] No abstract available.

PMID:
30922726
10.

Reply To: A Comment on Helicobacter pylori and Lung Transplant Outcome: Is Serology the Ideal Diagnostic Approach?

Bennett D, Rottoli P, Figura N.

Lung. 2019 Jun;197(3):393-394. doi: 10.1007/s00408-019-00220-9. No abstract available.

PMID:
30900015
11.

Serial KL-6 analysis in patients with idiopathic pulmonary fibrosis treated with nintedanib.

Bergantini L, Bargagli E, Cameli P, Cekorja B, Lanzarone N, Pianigiani L, Vietri L, Bennett D, Sestini P, Rottoli P.

Respir Investig. 2019 May;57(3):290-291. doi: 10.1016/j.resinv.2019.02.001. Epub 2019 Feb 21. No abstract available.

PMID:
30799155
12.

Pirfenidone Therapy for Familial Pulmonary Fibrosis: A Real-Life Study.

Bennett D, Refini RM, Valentini ML, Fui A, Fossi A, Pieroni M, Mazzei MA, Rottoli P.

Lung. 2019 Apr;197(2):147-153. doi: 10.1007/s00408-019-00203-w. Epub 2019 Feb 13.

PMID:
30758708
13.

Diagnosis of idiopathic pulmonary fibrosis by virtual means using "IPFdatabase"- a new software.

Bennett D, Mazzei MA, Collins B, Bargagli E, Pipavath S, Spina D, Valentini ML, Rinaldi C, Bettini G, Ginori A, Refini RM, Rottoli P, Raghu G.

Respir Med. 2019 Feb;147:31-36. doi: 10.1016/j.rmed.2018.12.011. Epub 2019 Jan 3.

PMID:
30704696
14.

Evaluation of multiple-flows exhaled nitric oxide in idiopathic and non-idiopathic interstitial lung disease.

Cameli P, Bargagli E, Bergantini L, Refini RM, Pieroni M, Sestini P, Rottoli P.

J Breath Res. 2019 Mar 27;13(2):026008. doi: 10.1088/1752-7163/ab0233.

PMID:
30690441
15.

Calgranulin B and KL-6 in Bronchoalveolar Lavage of Patients with IPF and NSIP.

Bennett D, Salvini M, Fui A, Cillis G, Cameli P, Mazzei MA, Fossi A, Refini RM, Rottoli P.

Inflammation. 2019 Apr;42(2):463-470. doi: 10.1007/s10753-018-00955-2.

PMID:
30680696
16.

The prognostic role of Gender-Age-Physiology system in idiopathic pulmonary fibrosis patients treated with pirfenidone.

Harari S, Caminati A, Confalonieri M, Poletti V, Vancheri C, Pesci A, Rogliani P, Luppi F, Agostini C, Rottoli P, Sanduzzi Zamparelli A, Sebastiani A, Della Porta R, Salton F, Messore B, Tomassetti S, Rosso R, Biffi A, Puxeddu E, Cerri S, Cinetto F, Refini RM, Bocchino M, Di Michele L, Specchia C, Albera C; ILDINET (Interstitial Lung Diseases Italian Network).

Clin Respir J. 2019 Mar;13(3):166-173. doi: 10.1111/crj.12999.

PMID:
30675755
17.

Postoperative acute kidney injury in lung transplant recipients.

Bennett D, Fossi A, Marchetti L, Lanzarone N, Sisi S, Refini RM, Sestini P, Luzzi L, Paladini P, Rottoli P.

Interact Cardiovasc Thorac Surg. 2019 Jun 1;28(6):929-935. doi: 10.1093/icvts/ivy355.

PMID:
30649317
18.

Helicobacter pylori Infection Does Not Impact on Lung Transplant Outcome.

Bennett D, Fossi A, Chiarello G, Refini RM, Luzzi L, Paladini P, Materozzi M, Figura N, Nuti R, Rottoli P.

Lung. 2019 Feb;197(1):95-99. doi: 10.1007/s00408-018-0178-7. Epub 2018 Nov 19.

PMID:
30456701
19.

Improvement of patient-reported outcomes in severe allergic asthma by omalizumab treatment: the real life observational PROXIMA study.

Canonica GW, Rottoli P, Bucca C, Zappa MC, Michetti G, Macciocchi B, Caruso C, Santus P, Bartezaghi M, Rigoni L; PROXIMA study centers.

World Allergy Organ J. 2018 Nov 1;11(1):33. doi: 10.1186/s40413-018-0214-3. eCollection 2018.

20.

Sarcoidosis: proteomics and new perspectives for improving personalized medicine.

Landi C, Carleo A, Cillis G, Rottoli P.

Expert Rev Proteomics. 2018 Oct;15(10):829-835. doi: 10.1080/14789450.2018.1528148. Epub 2018 Sep 28. Review.

PMID:
30251559
21.

Bronchoalveolar lavage proteomic analysis in pulmonary fibrosis associated with systemic sclerosis: S100A6 and 14-3-3ε as potential biomarkers.

Landi C, Bargagli E, Carleo A, Refini RM, Bennett D, Bianchi L, Cillis G, Prasse A, Bini L, Rottoli P.

Rheumatology (Oxford). 2019 Jan 1;58(1):165-178. doi: 10.1093/rheumatology/key223.

PMID:
30239835
22.

Airway-Centered Pleuroparenchymal Fibroelastosis Associated with Non-Necrotizing Granulomas: A Rare New Entity.

Bargagli E, Rottoli P, Torricelli E, Allegrini C, Dubini A, Bennett D, Luzzi L, Spina D, Poletti V, Tomassetti S.

Pathobiology. 2018;85(5-6):276-279. doi: 10.1159/000492431. Epub 2018 Sep 17.

PMID:
30223268
23.

BAL Cell Gene Expression Is Indicative of Outcome and Airway Basal Cell Involvement in Idiopathic Pulmonary Fibrosis.

Prasse A, Binder H, Schupp JC, Kayser G, Bargagli E, Jaeger B, Hess M, Rittinghausen S, Vuga L, Lynn H, Violette S, Jung B, Quast K, Vanaudenaerde B, Xu Y, Hohlfeld JM, Krug N, Herazo-Maya JD, Rottoli P, Wuyts WA, Kaminski N.

Am J Respir Crit Care Med. 2019 Mar 1;199(5):622-630. doi: 10.1164/rccm.201712-2551OC.

PMID:
30141961
24.

A Real-Life Multicenter National Study on Nintedanib in Severe Idiopathic Pulmonary Fibrosis.

Harari S, Caminati A, Poletti V, Confalonieri M, Gasparini S, Lacedonia D, Luppi F, Pesci A, Sebastiani A, Spagnolo P, Vancheri C, Balestro E, Bonifazi M, Cerri S, De Giacomi F, Della Porta R, Foschino Barbaro MP, Fui A, Pasquinelli P, Rosso R, Tomassetti S, Specchia C, Rottoli P; for the ILDINET (Interstitial Lung Diseases Italian Network).

Respiration. 2018;95(6):433-440. doi: 10.1159/000487711. Epub 2018 Mar 27.

25.

Phenotypes of organ involvement in sarcoidosis.

Schupp JC, Freitag-Wolf S, Bargagli E, Mihailović-Vučinić V, Rottoli P, Grubanovic A, Müller A, Jochens A, Tittmann L, Schnerch J, Olivieri C, Fischer A, Jovanovic D, Filipovic S, Videnovic-Ivanovic J, Bresser P, Jonkers R, O'Reilly K, Ho LP, Gaede KI, Zabel P, Dubaniewicz A, Marshall B, Kieszko R, Milanowski J, Günther A, Weihrich A, Petrek M, Kolek V, Keane MP, O'Beirne S, Donnelly S, Haraldsdottir SO, Jorundsdottir KB, Costabel U, Bonella F, Wallaert B, Grah C, Peroš-Golubičić T, Luisetti M, Kadija Z, Pabst S, Grohé C, Strausz J, Vašáková M, Sterclova M, Millar A, Homolka J, Slováková A, Kendrick Y, Crawshaw A, Wuyts W, Spencer L, Pfeifer M, Valeyre D, Poletti V, Wirtz H, Prasse A, Schreiber S, Krawczak M, Müller-Quernheim J.

Eur Respir J. 2018 Jan 25;51(1). pii: 1700991. doi: 10.1183/13993003.00991-2017. Print 2018 Jan.

26.

Home oxygen therapy: re-thinking the role of devices.

Melani AS, Sestini P, Rottoli P.

Expert Rev Clin Pharmacol. 2018 Mar;11(3):279-289. doi: 10.1080/17512433.2018.1421457. Epub 2018 Jan 4. Review.

PMID:
29272974
27.

The pharmacological treatment of bronchiectasis.

Melani AS, Lanzarone N, Rottoli P.

Expert Rev Clin Pharmacol. 2018 Mar;11(3):245-258. doi: 10.1080/17512433.2018.1421064. Epub 2018 Jan 10. Review.

PMID:
29268637
28.

Increased Risk of Atherosclerosis in Patients with Sarcoidosis.

Bargagli E, Rosi E, Pistolesi M, Lavorini F, Voltolini L, Rottoli P.

Pathobiology. 2017;84(5):258-263. doi: 10.1159/000477736. Epub 2017 Aug 10. Review.

29.

Familial pulmonary fibrosis: Clinical and radiological characteristics and progression analysis in different high resolution-CT patterns.

Bennett D, Mazzei MA, Squitieri NC, Bargagli E, Refini RM, Fossi A, Volterrani L, Rottoli P.

Respir Med. 2017 May;126:75-83. doi: 10.1016/j.rmed.2017.03.020. Epub 2017 Mar 22.

30.

Bronchial stenosis following lung transplant: an innovative approach with a modified endobronchial emphysema valve.

Ghiribelli C, Bennett D, Paladini P, Fossi A, Rottoli P.

Clin Respir J. 2018 Feb;12(2):835-836. doi: 10.1111/crj.12596. Epub 2016 Dec 26. No abstract available.

PMID:
27925433
31.

Cavernous sinus syndrome due to neurosarcoidosis in adolescence: a diagnosis not to be missed.

Rosini F, Bennett D, Cerase A, Volterrani L, Federico A, Rottoli P, Rufa A.

Neurol Sci. 2017 Mar;38(3):517-519. doi: 10.1007/s10072-016-2753-0. Epub 2016 Nov 23. No abstract available.

PMID:
27882437
32.

Posttransplant solid organ malignancies in lung transplant recipients: a single-center experience and review of the literature.

Bennett D, Fossi A, Refini RM, Gentili F, Luzzi L, Voltolini L, Paladini P, Mazzei MA, Rottoli P.

Tumori. 2016 Dec 1;102(6):574-581. doi: 10.5301/tj.5000557. Epub 2016 Aug 23. Review.

PMID:
27647228
33.

Biomarkers in sarcoidosis: the contribution of system biology.

Carleo A, Bennett D, Rottoli P.

Curr Opin Pulm Med. 2016 Sep;22(5):509-14. doi: 10.1097/MCP.0000000000000306. Review.

PMID:
27428796
34.

Idiopathic pulmonary fibrosis a rare disease with severe bone fragility.

Caffarelli C, Gonnelli S, Tomai Pitinca MD, Francolini V, Fui A, Bargagli E, Refini RM, Bennett D, Nuti R, Rottoli P.

Intern Emerg Med. 2016 Dec;11(8):1087-1094. Epub 2016 Jul 8.

PMID:
27393142
35.

Macrophage migration inhibitory factor in lung tissue of idiopathic pulmonary fibrosis patients.

Olivieri C, Bargagli E, Inghilleri S, Campo I, Cintorino M, Rottoli P.

Exp Lung Res. 2016 Jun;42(5):263-6. doi: 10.1080/01902148.2016.1199744. Epub 2016 Jun 23.

PMID:
27337548
36.

Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A randomized controlled multicenter clinical trial.

Vitulo P, Stanziola A, Confalonieri M, Libertucci D, Oggionni T, Rottoli P, Paciocco G, Tuzzolino F, Martino L, Beretta M, Callari A, Amaducci A, Badagliacca R, Poscia R, Meloni F, Refini RM, Geri P, Baldi S, Ghio S, D'Alto M, Argiento P, Sofia M, Guardamagna M, Pezzuto B, Vizza CD.

J Heart Lung Transplant. 2017 Feb;36(2):166-174. doi: 10.1016/j.healun.2016.04.010. Epub 2016 May 7.

PMID:
27329400
37.

Comparative proteomic analysis of bronchoalveolar lavage of familial and sporadic cases of idiopathic pulmonary fibrosis.

Carleo A, Bargagli E, Landi C, Bennett D, Bianchi L, Gagliardi A, Carnemolla C, Perari MG, Cillis G, Armini A, Bini L, Rottoli P.

J Breath Res. 2016 Apr 15;10(2):026007. doi: 10.1088/1752-7155/10/2/026007.

PMID:
27082636
38.

Exhaled nitric oxide is not increased in pulmonary sarcoidosis.

Cameli P, Barbagli E, Rottoli P.

Sarcoidosis Vasc Diffuse Lung Dis. 2016 Mar 29;33(1):39-40.

PMID:
27055834
39.

A functional proteomics approach to the comprehension of sarcoidosis.

Landi C, Bargagli E, Carleo A, Bianchi L, Gagliardi A, Cillis G, Perari MG, Refini RM, Prasse A, Bini L, Rottoli P.

J Proteomics. 2015 Oct 14;128:375-87. doi: 10.1016/j.jprot.2015.08.012. Epub 2015 Sep 2.

PMID:
26342673
40.

Exhaled nitric oxide and carbon monoxide in lung transplanted patients.

Cameli P, Bargagli E, Fossi A, Bennett D, Voltolini L, Refini RM, Gotti G, Rottoli P.

Respir Med. 2015 Sep;109(9):1224-9. doi: 10.1016/j.rmed.2015.07.005. Epub 2015 Jul 9.

41.

Mortality on the Waiting List for Lung Transplantation in Patients with Idiopathic Pulmonary Fibrosis: A Single-Centre Experience.

Bennett D, Fossi A, Bargagli E, Refini RM, Pieroni M, Luzzi L, Ghiribelli C, Paladini P, Voltolini L, Rottoli P.

Lung. 2015 Oct;193(5):677-81. doi: 10.1007/s00408-015-9767-x. Epub 2015 Jul 28.

PMID:
26216722
42.

Acute exacerbation of idiopathic pulmonary fibrosis after inhalation of a water repellent.

Bennett D, Bargagli E, Refini RM, Pieroni MG, Fossi A, Romeo R, Volterrani L, Mazzei MA, Rottoli P.

Int J Occup Med Environ Health. 2015;28(4):775-9. doi: 10.13075/ijomeh.1896.00462.

43.

Catching allergy by a simple questionnaire.

Galimberti M, Passalacqua G, Incorvaia C, Castella V, Costantino MT, Cucchi B, Gangemi S, Nardi G, Raviolo P, Rottoli P, Scichilone N, Sciolla N, Bettoncelli G, Landi M, Ridolo E, Buttafava S, Puccinelli P, Canonica GW, Fiocchi A, Frati F.

World Allergy Organ J. 2015 Jun 11;8(1):16. doi: 10.1186/s40413-015-0067-y. eCollection 2015.

44.

Role of BNP and echo measurement for pulmonary hypertension recognition in patients with interstitial lung disease: An algorithm application model.

Ruocco G, Cekorja B, Rottoli P, Refini RM, Pellegrini M, Di Tommaso C, Del Castillo G, Franci B, Nuti R, Palazzuoli A.

Respir Med. 2015 Mar;109(3):406-15. doi: 10.1016/j.rmed.2014.12.011. Epub 2015 Jan 3.

45.

A system biology study of BALF from patients affected by idiopathic pulmonary fibrosis (IPF) and healthy controls.

Landi C, Bargagli E, Carleo A, Bianchi L, Gagliardi A, Prasse A, Perari MG, Refini RM, Bini L, Rottoli P.

Proteomics Clin Appl. 2014 Dec;8(11-12):932-50. doi: 10.1002/prca.201400001. Epub 2014 Oct 22.

PMID:
25169739
46.

The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool.

Judson MA, Costabel U, Drent M, Wells A, Maier L, Koth L, Shigemitsu H, Culver DA, Gelfand J, Valeyre D, Sweiss N, Crouser E, Morgenthau AS, Lower EE, Azuma A, Ishihara M, Morimoto S, Tetsuo Yamaguchi T, Shijubo N, Grutters JC, Rosenbach M, Li HP, Rottoli P, Inoue Y, Prasse A, Baughman RP, Organ Assessment Instrument Investigators TW.

Sarcoidosis Vasc Diffuse Lung Dis. 2014 Apr 18;31(1):19-27.

PMID:
24751450
47.

Exhaled nitric oxide in interstitial lung diseases.

Cameli P, Bargagli E, Refini RM, Pieroni MG, Bennett D, Rottoli P.

Respir Physiol Neurobiol. 2014 Jun 15;197:46-52. doi: 10.1016/j.resp.2014.03.011. Epub 2014 Apr 2.

PMID:
24703971
48.

Diffuse panbronchiolitis in a patient with common variable immunodeficiency: a casual association or a pathogenetic correlation?

Ginori A, Barone A, Bennett D, Butorano MA, Mastrogiulio MG, Fossi A, Rottoli P, Spina D.

Diagn Pathol. 2014 Jan 20;9:12. doi: 10.1186/1746-1596-9-12.

49.

Helicobacter pylori seroprevalence in patients with idiopathic pulmonary fibrosis.

Bennett D, Bargagli E, Refini RM, Campagna MS, Gennari L, Nuti R, Figura N, Rottoli P.

Eur Respir J. 2014 Feb;43(2):635-8. doi: 10.1183/09031936.00104813. Epub 2013 Oct 10. No abstract available.

50.

TLR7 Gln11Leu single nucleotide polymorphism in patients with sarcoidosis.

Bordignon M, Bargagli E, Agostini C, Cinetto F, Baldo V, Alaibac M, Rottoli P.

Sarcoidosis Vasc Diffuse Lung Dis. 2013 Aug 1;30(2):157-61.

PMID:
24071890

Supplemental Content

Loading ...
Support Center